These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 478338)

  • 21. Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report.
    Kane RD; Stocks LH; Paulson DF
    J Urol; 1977 Apr; 117(4):467-71. PubMed ID: 850320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
    Pouillart R; Huong TH; Brugerie E; Lheritier J
    Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
    Smalley RV; Murphy S; Huguley CM; Bartolucci AA
    Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment and immunodiagnosis of advanced ovarian adenocarcinoma: a preliminary report.
    Piver MS; Barlow JJ; Bhattacharya M
    Cancer Treat Rep; 1979 Feb; 63(2):265-7. PubMed ID: 376133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologic grade in advanced ovarian cancer.
    Ozols RF; Garvin AJ; Costa J; Simon RM; Young RC
    Cancer Treat Rep; 1979 Feb; 63(2):255-63. PubMed ID: 109199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trials of single-agent and combination chemotherapy for advanced cancer of the pancreas.
    Horton J; Gelber RD; Engstrom P; Falkson G; Moertel C; Brodovsky H; Douglass H
    Cancer Treat Rep; 1981; 65(1-2):65-8. PubMed ID: 6452948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination chemotherapy in the treatment of cancer].
    Goldenson Y; Lev L; Robinson E
    Harefuah; 1972 Aug; 83(4):157-60. PubMed ID: 4628451
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy in advanced ovarian cancer.
    Smith JP; Rutledge FN
    Natl Cancer Inst Monogr; 1975 Oct; 42():141-3. PubMed ID: 825776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antineoplastic activity of combinations of cytostatics and dextran-ferrite administered to mice with leukemia P-388].
    Brusentsov NA; Glazkova TIu; Iavorskaia NP; Iurchenko NIa
    Eksp Onkol; 1990; 12(6):59-60. PubMed ID: 2261881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Etoposide (VP-16) in gynecologic malignancy].
    Kanazawa K; Moromizato H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1925-8. PubMed ID: 8978799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of the Gynecologic Oncology Group trials on ovarian cancer: preliminary report.
    Hreshchyshyn MM
    Natl Cancer Inst Monogr; 1975 Oct; 42():155-65. PubMed ID: 1234633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of "5-drug" treatment of advanced breast cancer].
    Dorociak R
    Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
    [No Abstract]   [Full Text] [Related]  

  • 35. Results of the Royal Marsden Hospital second soft tissue sarcoma schedule (STS II) chemotherapy regimen in the management of advanced sarcoma.
    Bryant BM; Wiltshaw E
    Cancer Treat Rep; 1980; 64(4-5):689-92. PubMed ID: 7000348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental chemotherapy in carcinoma of the cervix.
    Papadimitriou G; Razis D; Panopoulos C; Lappas C; Gnafakis N
    Int Surg; 1974 Sep; 59(9):472-5. PubMed ID: 4137657
    [No Abstract]   [Full Text] [Related]  

  • 37. [1st report on programmed chemotherapy of ovarian carcinoma].
    Frank S; Richter K; Ehrhart H; Penning W; Meister P; Schmidt D; Götz A
    Fortschr Med; 1975 Oct; 93(28):1309-12. PubMed ID: 1228086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress in the chemotherapy of ovarian cancer].
    Honetz N
    Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
    Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract]   [Full Text] [Related]  

  • 40. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
    Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C
    Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.